Maira M. Pires, Ph.D.
Affiliations: | 2013 | Biochemistry and Molecular Biophysics | Columbia University, New York, NY |
Area:
Molecular Biology, OncologyGoogle:
"Maira Pires"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ramon E. Parsons | grad student | 2013 | Columbia | |
| (Basal-like breast cancer: Modeling its initiation and characterizing novel EGFR variants.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lau YK, Du X, Rayannavar V, et al. (2014) Metformin and erlotinib synergize to inhibit basal breast cancer. Oncotarget. 5: 10503-17 |
| Pires MM, Aaronson SA. (2014) Brachyury: a new player in promoting breast cancer aggressiveness. Journal of the National Cancer Institute. 106 |
| Marshall N, Sanchez F, Llobet D, et al. (2014) Abstract 432: BIN3 is a novel 8p21 tumor suppressor gene that regulates the attachment checkpoint in epithelial cells Cancer Research. 74: 432-432 |
| Keniry M, Pires MM, Mense S, et al. (2013) Survival factor NFIL3 restricts FOXO-induced gene expression in cancer. Genes & Development. 27: 916-27 |
| Pires MM, Hopkins BD, Saal LH, et al. (2013) Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells. Cancer Biology & Therapy. 14: 246-53 |
| Lau Y, Pires M, Shaw J, et al. (2010) Abstract PD03-05: A Novel Combination Therapy for Triple Negative Breast Cancer: Erlotinib and Metformin Cancer Research. 70 |
| Saal LH, Gruvberger-Saal SK, Persson C, et al. (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nature Genetics. 40: 102-7 |